Skip to main content
Top
Published in: Inflammopharmacology 2/2024

21-03-2024 | Irritable Bowel Syndrome | Review

Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis

Author: Bruno Bonaz

Published in: Inflammopharmacology | Issue 2/2024

Login to get access

Abstract

The gut and the brain communicate bidirectionally through the autonomic nervous system. The vagus nerve is a key component of this gut–brain axis, and has numerous properties such as anti-inflammatory, antinociceptive, anti-depressive effects. A perturbation of this gut–brain communication is involved in the pathogeny of functional digestive disorders, such as irritable bowel syndrome, and inflammatory bowel diseases. Stress plays a role in the pathogeny of these diseases, which are biopsychosocial models. There are presently unmet needs of pharmacological treatments of these chronic debilitating diseases. Treatments are not devoid of side effects, cost-effective, do not cure the diseases, can lose effects over time, thus explaining the poor satisfaction of patients, their lack of compliance, and their interest for non-drug therapies. The gut–brain axis can be targeted for therapeutic purposes in irritable bowel syndrome and inflammatory bowel disease through non-drug therapies, such as hypnosis and vagus nerve stimulation, opening up possibilities for responding to patient expectations.
Literature
go back to reference Artru-Voegelé S, Sinniger V, Batandier C, Troprès I, Pellissier S, Bonaz B (2022) Contributions of hypnosis in Crohn’s disease management: interests and preliminary results of HypnoCrohn study. Hegel 12:199–212CrossRef Artru-Voegelé S, Sinniger V, Batandier C, Troprès I, Pellissier S, Bonaz B (2022) Contributions of hypnosis in Crohn’s disease management: interests and preliminary results of HypnoCrohn study. Hegel 12:199–212CrossRef
go back to reference Badran BW, Yu AB, Adair D, Mappin G, DeVries WH, Jenkins DD, George MS, Bikson M (2019) Laboratory administration of transcutaneous auricular vagus nerve stimulation (taVNS): technique, targeting, and considerations. J Vis Exp 14310.3791/58984. Badran BW, Yu AB, Adair D, Mappin G, DeVries WH, Jenkins DD, George MS, Bikson M (2019) Laboratory administration of transcutaneous auricular vagus nerve stimulation (taVNS): technique, targeting, and considerations. J Vis Exp 14310.3791/58984.
go back to reference Ben-Horin S, Chowers Y (2011) Review article: loss of response to anti-TNF treatments in Crohn’s disease. Aliment Pharmacol Ther 33(9):987–995PubMedCrossRef Ben-Horin S, Chowers Y (2011) Review article: loss of response to anti-TNF treatments in Crohn’s disease. Aliment Pharmacol Ther 33(9):987–995PubMedCrossRef
go back to reference Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC (2020a) Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 5(2):117–131PubMedCrossRef Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC (2020a) Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 5(2):117–131PubMedCrossRef
go back to reference Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC (2020b) Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut 69(8):1441–1451PubMedCrossRef Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC (2020b) Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut 69(8):1441–1451PubMedCrossRef
go back to reference Bonaz B (2022) Anti-inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction. Neurogastroenterol Motil 34(10):e14456PubMedPubMedCentralCrossRef Bonaz B (2022) Anti-inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction. Neurogastroenterol Motil 34(10):e14456PubMedPubMedCentralCrossRef
go back to reference Bonaz BL, Bernstein CN (2013) Brain-gut interactions in inflammatory bowel disease. Gastroenterology 144(1):36–49PubMedCrossRef Bonaz BL, Bernstein CN (2013) Brain-gut interactions in inflammatory bowel disease. Gastroenterology 144(1):36–49PubMedCrossRef
go back to reference Bonaz B, Picq C, Sinniger V, Mayol JF, Clarençon D (2013) Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil 25(3):208–221PubMedCrossRef Bonaz B, Picq C, Sinniger V, Mayol JF, Clarençon D (2013) Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil 25(3):208–221PubMedCrossRef
go back to reference Bonaz B, Sinniger V, Hoffmann D, Clarençon D, Mathieu N, Dantzer C, Vercueil L, Picq C, Trocmé C, Faure P, Cracowski JL, Pellissier S (2016) Chronic vagus nerve stimulation in Crohn’s disease: a 6-month follow-up pilot study. Neurogastroenterol Motil 28(6):948–953PubMedCrossRef Bonaz B, Sinniger V, Hoffmann D, Clarençon D, Mathieu N, Dantzer C, Vercueil L, Picq C, Trocmé C, Faure P, Cracowski JL, Pellissier S (2016) Chronic vagus nerve stimulation in Crohn’s disease: a 6-month follow-up pilot study. Neurogastroenterol Motil 28(6):948–953PubMedCrossRef
go back to reference Bonaz B, Sinniger V, Pellissier S (2017) The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol 8:1452PubMedPubMedCentralCrossRef Bonaz B, Sinniger V, Pellissier S (2017) The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol 8:1452PubMedPubMedCentralCrossRef
go back to reference Bonaz B, Lane RD, Oshinsky ML, Kenny PJ, Sinha R, Mayer EA, Critchley HD (2021b) Diseases, Disorders, and Comorbidities of Interoception. Trends Neurosci 44(1):39–51PubMedCrossRef Bonaz B, Lane RD, Oshinsky ML, Kenny PJ, Sinha R, Mayer EA, Critchley HD (2021b) Diseases, Disorders, and Comorbidities of Interoception. Trends Neurosci 44(1):39–51PubMedCrossRef
go back to reference Boot WR, Simons DJ, Stothart C, Stutts C (2013) The Pervasive Problem With Placebos in Psychology: Why Active Control Groups Are Not Sufficient to Rule Out Placebo Effects. Perspect Psychol Sci 8(4):445–454PubMedCrossRef Boot WR, Simons DJ, Stothart C, Stutts C (2013) The Pervasive Problem With Placebos in Psychology: Why Active Control Groups Are Not Sufficient to Rule Out Placebo Effects. Perspect Psychol Sci 8(4):445–454PubMedCrossRef
go back to reference Brock C, Brock B, Aziz Q, Møller HJ, Pfeiffer Jensen M, Drewes AM, Farmer AD (2017) Transcutaneous cervical vagal nerve stimulation modulates cardiac vagal tone and Tumor necrosis factor-alpha. Neurogastroenterol Motil 29(5). Brock C, Brock B, Aziz Q, Møller HJ, Pfeiffer Jensen M, Drewes AM, Farmer AD (2017) Transcutaneous cervical vagal nerve stimulation modulates cardiac vagal tone and Tumor necrosis factor-alpha. Neurogastroenterol Motil 29(5).
go back to reference Brown DW, Anda RF, Tiemeier H, Felitti VJ, Edwards VJ, Croft JB, Giles WH (2009) Adverse childhood experiences and the risk of premature mortality. Am J Prev Med 37(5):389–396PubMedCrossRef Brown DW, Anda RF, Tiemeier H, Felitti VJ, Edwards VJ, Croft JB, Giles WH (2009) Adverse childhood experiences and the risk of premature mortality. Am J Prev Med 37(5):389–396PubMedCrossRef
go back to reference Chaparro M, Guerra I, Muñoz-Linares P, Gisbert JP (2012) Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease. Aliment Pharmacol Ther 35(9):971–986PubMedCrossRef Chaparro M, Guerra I, Muñoz-Linares P, Gisbert JP (2012) Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease. Aliment Pharmacol Ther 35(9):971–986PubMedCrossRef
go back to reference Dent E, Davinson N, Wilkie S (2022) The impact of gastrointestinal conditions on psychosocial factors associated with the biopsychosocial model of health: A scoping review. Appl Psychol Health Well Being 14(2):626–644PubMedCrossRef Dent E, Davinson N, Wilkie S (2022) The impact of gastrointestinal conditions on psychosocial factors associated with the biopsychosocial model of health: A scoping review. Appl Psychol Health Well Being 14(2):626–644PubMedCrossRef
go back to reference Devenney J, Hasan SS, Morris J, Whorwell PJ, Vasant DH (2024) Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis. Aliment Pharmacol Ther 59(2):269–277PubMedCrossRef Devenney J, Hasan SS, Morris J, Whorwell PJ, Vasant DH (2024) Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis. Aliment Pharmacol Ther 59(2):269–277PubMedCrossRef
go back to reference D'Haens G, Eberhardson M, Cabrijan Z, Danese S, van den Berg R, Löwenberg M, Fiorino G, Schuurman PR, Lind G, Almqvist P, Olofsson PS, Tracey KJ, Hanauer SB, Zitnik R, Chernoff D, Levine YA (2023) Neuroimmune modulation through vagus nerve stimulation reduces inflammatory activity in Crohn's disease patients: a prospective open label study. J Crohns Colitis Sep 21:jjad151. D'Haens G, Eberhardson M, Cabrijan Z, Danese S, van den Berg R, Löwenberg M, Fiorino G, Schuurman PR, Lind G, Almqvist P, Olofsson PS, Tracey KJ, Hanauer SB, Zitnik R, Chernoff D, Levine YA (2023) Neuroimmune modulation through vagus nerve stimulation reduces inflammatory activity in Crohn's disease patients: a prospective open label study. J Crohns Colitis Sep 21:jjad151.
go back to reference Drewes AM, Brock C, Rasmussen SE, Møller HJ, Brock B, Deleuran BW, Farmer AD, Pfeiffer-Jensen M (2021) Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study. Scand J Rheumatol 50(1):20–27PubMedCrossRef Drewes AM, Brock C, Rasmussen SE, Møller HJ, Brock B, Deleuran BW, Farmer AD, Pfeiffer-Jensen M (2021) Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study. Scand J Rheumatol 50(1):20–27PubMedCrossRef
go back to reference Drossman DA, Tack J, Ford AC, Szigethy E, Törnblom H, Van Oudenhove L (2018) Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome foundation working team report. Gastroenterology 154(4):1140–1171PubMedCrossRef Drossman DA, Tack J, Ford AC, Szigethy E, Törnblom H, Van Oudenhove L (2018) Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome foundation working team report. Gastroenterology 154(4):1140–1171PubMedCrossRef
go back to reference Ducarouge B, Pelissier-Rota M, Powell R, Buisson A, Bonaz B, Jacquier-Sarlin M (2017) Involvement of CRF2 signaling in enterocyte differentiation. World J Gastroenterol 23(28):5127–5145PubMedPubMedCentralCrossRef Ducarouge B, Pelissier-Rota M, Powell R, Buisson A, Bonaz B, Jacquier-Sarlin M (2017) Involvement of CRF2 signaling in enterocyte differentiation. World J Gastroenterol 23(28):5127–5145PubMedPubMedCentralCrossRef
go back to reference Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC (2020) Prevalence of irritable bowel syndrome type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 5(12):1053–1062PubMedCrossRef Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC (2020) Prevalence of irritable bowel syndrome type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 5(12):1053–1062PubMedCrossRef
go back to reference Flik CE, Laan W, Zuithoff NPA, van Rood YR, Smout AJPM, Weusten BLAM, Whorwell PJ, de Wit NJ (2019) Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 4(1):20–31PubMedCrossRef Flik CE, Laan W, Zuithoff NPA, van Rood YR, Smout AJPM, Weusten BLAM, Whorwell PJ, de Wit NJ (2019) Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 4(1):20–31PubMedCrossRef
go back to reference Ford AC, Moayyedi P (2010) Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther 32(2):144–158PubMedCrossRef Ford AC, Moayyedi P (2010) Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther 32(2):144–158PubMedCrossRef
go back to reference Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA, ATLANTIS trialists, (2023) Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 402(10414):1773–1785PubMedCrossRef Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA, ATLANTIS trialists, (2023) Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 402(10414):1773–1785PubMedCrossRef
go back to reference Fournier A, Mondillon L, Luminet O, Canini F, Mathieu N, Gauchez AS, Dantzer C, Bonaz B, Pellissier S (2020) Interoceptive abilities in inflammatory bowel diseases and irritable bowel syndrome. Front Psychiatry 11:229PubMedPubMedCentralCrossRef Fournier A, Mondillon L, Luminet O, Canini F, Mathieu N, Gauchez AS, Dantzer C, Bonaz B, Pellissier S (2020) Interoceptive abilities in inflammatory bowel diseases and irritable bowel syndrome. Front Psychiatry 11:229PubMedPubMedCentralCrossRef
go back to reference Ghosh S, Sinha JK, Ghosh S, Sharma H, Bhaskar R, Narayanan KB (2023) A comprehensive review of emerging trends and innovative therapies in epilepsy management. Brain Sci Sep 13(9):1305. Ghosh S, Sinha JK, Ghosh S, Sharma H, Bhaskar R, Narayanan KB (2023) A comprehensive review of emerging trends and innovative therapies in epilepsy management. Brain Sci Sep 13(9):1305.
go back to reference Go YY, Ju WM, Lee CM, Chae SW, Song JJ (2022) Different transcutaneous auricular vagus nerve stimulation parameters modulate the anti-inflammatory effects on lipopolysaccharide-induced acute inflammation in mice. Biomedicines 10(2):247PubMedPubMedCentralCrossRef Go YY, Ju WM, Lee CM, Chae SW, Song JJ (2022) Different transcutaneous auricular vagus nerve stimulation parameters modulate the anti-inflammatory effects on lipopolysaccharide-induced acute inflammation in mice. Biomedicines 10(2):247PubMedPubMedCentralCrossRef
go back to reference Godoy LC, Frankfurter C, Cooper M, Lay C, Maunder R, Farkouh ME (2021) Association of adverse childhood experiences with cardiovascular disease later in life: a review. JAMA Cardiol 6(2):228–235PubMedCrossRef Godoy LC, Frankfurter C, Cooper M, Lay C, Maunder R, Farkouh ME (2021) Association of adverse childhood experiences with cardiovascular disease later in life: a review. JAMA Cardiol 6(2):228–235PubMedCrossRef
go back to reference Gwee KA (2010) Post-infectious irritable bowel syndrome, an inflammation-immunological model with relevance for other ibs and functional dyspepsia. J Neurogastroenterol Motil 16(1):30–34PubMedPubMedCentralCrossRef Gwee KA (2010) Post-infectious irritable bowel syndrome, an inflammation-immunological model with relevance for other ibs and functional dyspepsia. J Neurogastroenterol Motil 16(1):30–34PubMedPubMedCentralCrossRef
go back to reference Halkjær SI, Lo B, Cold F, Højer Christensen A, Holster S, König J, Brummer RJ, Aroniadis OC, Lahtinen P, Holvoet T, Gluud LL, Petersen AM (2023) Fecal microbiota transplantation for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. World J Gastroenterol 29(20):3185–3202PubMedPubMedCentralCrossRef Halkjær SI, Lo B, Cold F, Højer Christensen A, Holster S, König J, Brummer RJ, Aroniadis OC, Lahtinen P, Holvoet T, Gluud LL, Petersen AM (2023) Fecal microbiota transplantation for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. World J Gastroenterol 29(20):3185–3202PubMedPubMedCentralCrossRef
go back to reference Hasan SS, Pearson JS, Morris J, Whorwell PJ (2019) Skype hypnotherapy for irritable bowel syndrome: effectiveness and comparison with face-to-face treatment. Int J Clin Exp Hypn 67(1):69–80PubMedPubMedCentralCrossRef Hasan SS, Pearson JS, Morris J, Whorwell PJ (2019) Skype hypnotherapy for irritable bowel syndrome: effectiveness and comparison with face-to-face treatment. Int J Clin Exp Hypn 67(1):69–80PubMedPubMedCentralCrossRef
go back to reference Hasan SS, Whorwell PJ, Miller V, Morris J, Vasant DH (2021) Six vs 12 sessions of gut-focused hypnotherapy for irritable bowel syndrome: a randomized trial. Gastroenterology 160(7):2605-2607.e3PubMedCrossRef Hasan SS, Whorwell PJ, Miller V, Morris J, Vasant DH (2021) Six vs 12 sessions of gut-focused hypnotherapy for irritable bowel syndrome: a randomized trial. Gastroenterology 160(7):2605-2607.e3PubMedCrossRef
go back to reference Jänig W, Khasar SG, Levine JD, Miao FJ (2000) The role of vagal visceral afferents in the control of nociception. Prog Brain Res 122:273–287PubMedCrossRef Jänig W, Khasar SG, Levine JD, Miao FJ (2000) The role of vagal visceral afferents in the control of nociception. Prog Brain Res 122:273–287PubMedCrossRef
go back to reference Katibian DJ, Solitano V, Polk DB, Nguyen T, Ma C, Syal G, Kobayashi T, Hibi T, Buhl S, Ainsworth MA, Jairath V, Singh S (2024) Withdrawal of immunomodulators or TNF antagonists in patients with inflammatory bowel diseases in remission on combination therapy: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 22(1):22-33.e6PubMedCrossRef Katibian DJ, Solitano V, Polk DB, Nguyen T, Ma C, Syal G, Kobayashi T, Hibi T, Buhl S, Ainsworth MA, Jairath V, Singh S (2024) Withdrawal of immunomodulators or TNF antagonists in patients with inflammatory bowel diseases in remission on combination therapy: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 22(1):22-33.e6PubMedCrossRef
go back to reference Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS (2013) Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther 38(7):761–771PubMedPubMedCentralCrossRef Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS (2013) Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther 38(7):761–771PubMedPubMedCentralCrossRef
go back to reference Knox NC, Forbes JD, Van Domselaar G, Bernstein CN (2019) The gut microbiome as a target for IBD treatment: are we there yet? Curr Treat Options Gastroenterol 17(1):115–126PubMedCrossRef Knox NC, Forbes JD, Van Domselaar G, Bernstein CN (2019) The gut microbiome as a target for IBD treatment: are we there yet? Curr Treat Options Gastroenterol 17(1):115–126PubMedCrossRef
go back to reference Koloski NA, Talley NJ, Boyce PM (2000) The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 95:67–71PubMedCrossRef Koloski NA, Talley NJ, Boyce PM (2000) The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 95:67–71PubMedCrossRef
go back to reference Koren T, Yifa R, Amer M, Krot M, Boshnak N, Ben-Shaanan TL, Azulay-Debby H, Zalayat I, Avishai E, Hajjo H, Schiller M, Haykin H, Korin B, Farfara D, Hakim F, Kobiler O, Rosenblum K, Rolls A (2021) Insular cortex neurons encode and retrieve specific immune responses. Cell 184(24):5902-5915.e17PubMedCrossRef Koren T, Yifa R, Amer M, Krot M, Boshnak N, Ben-Shaanan TL, Azulay-Debby H, Zalayat I, Avishai E, Hajjo H, Schiller M, Haykin H, Korin B, Farfara D, Hakim F, Kobiler O, Rosenblum K, Rolls A (2021) Insular cortex neurons encode and retrieve specific immune responses. Cell 184(24):5902-5915.e17PubMedCrossRef
go back to reference Krahl SE, Clark KB, Smith DC, Browning RA (1998) Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39(7):709–714PubMedCrossRef Krahl SE, Clark KB, Smith DC, Browning RA (1998) Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39(7):709–714PubMedCrossRef
go back to reference Leigh SJ, Uhlig F, Wilmes L, Sanchez-Diaz P, Gheorghe CE, Goodson MS, Kelley-Loughnane N, Hyland NP, Cryan JF, Clarke G (2023) The impact of acute and chronic stress on gastrointestinal physiology and function: a microbiota-gut-brain axis perspective. J Physiol 601(20):4491–4538PubMedCrossRef Leigh SJ, Uhlig F, Wilmes L, Sanchez-Diaz P, Gheorghe CE, Goodson MS, Kelley-Loughnane N, Hyland NP, Cryan JF, Clarke G (2023) The impact of acute and chronic stress on gastrointestinal physiology and function: a microbiota-gut-brain axis perspective. J Physiol 601(20):4491–4538PubMedCrossRef
go back to reference Lewis JD, Parlett LE, Jonsson Funk ML, Brensinger C, Pate V, Wu Q, Dawwas GK, Weiss A, Constant BD, McCauley M, Haynes K, Yang JY, Schaubel DE, Hurtado-Lorenzo A, Kappelman MD (2023) Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology 165(5):1197–1205PubMedCrossRef Lewis JD, Parlett LE, Jonsson Funk ML, Brensinger C, Pate V, Wu Q, Dawwas GK, Weiss A, Constant BD, McCauley M, Haynes K, Yang JY, Schaubel DE, Hurtado-Lorenzo A, Kappelman MD (2023) Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology 165(5):1197–1205PubMedCrossRef
go back to reference Lindfors P, Unge P, Arvidsson P, Nyhlin H, Björnsson E, Abrahamsson H, Simrén M (2012) Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol 107(2):276–285PubMedCrossRef Lindfors P, Unge P, Arvidsson P, Nyhlin H, Björnsson E, Abrahamsson H, Simrén M (2012) Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol 107(2):276–285PubMedCrossRef
go back to reference Martínez-Vázquez MA, Vázquez-Elizondo G, González-González JA, Gutiérrez-Udave R, Maldonado-Garza HJ, Bosques-Padilla FJ (2012) Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: systematic review and meta-analysis. Rev Gastroenterol Mex 77(2):82–90PubMed Martínez-Vázquez MA, Vázquez-Elizondo G, González-González JA, Gutiérrez-Udave R, Maldonado-Garza HJ, Bosques-Padilla FJ (2012) Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: systematic review and meta-analysis. Rev Gastroenterol Mex 77(2):82–90PubMed
go back to reference Mawdsley JE, Jenkins DG, Macey MG, Langmead L, Rampton DS (2008) The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol 103(6):1460–1469PubMedCrossRef Mawdsley JE, Jenkins DG, Macey MG, Langmead L, Rampton DS (2008) The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol 103(6):1460–1469PubMedCrossRef
go back to reference Meregnani J, Clarençon D, Vivier M, Peinnequin A, Mouret C, Sinniger V, Picq C, Job A, Canini F, Jacquier-Sarlin M, Bonaz B (2011) Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 160(1–2):82–89PubMedCrossRef Meregnani J, Clarençon D, Vivier M, Peinnequin A, Mouret C, Sinniger V, Picq C, Job A, Canini F, Jacquier-Sarlin M, Bonaz B (2011) Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 160(1–2):82–89PubMedCrossRef
go back to reference Minjoz S, Sinniger V, Hot P, Bonaz B, Pellissier S (2023) The burden of early life stress in chronic inflammatory bowel diseases. J Health Psychol 28(13):1204–1216PubMedCrossRef Minjoz S, Sinniger V, Hot P, Bonaz B, Pellissier S (2023) The burden of early life stress in chronic inflammatory bowel diseases. J Health Psychol 28(13):1204–1216PubMedCrossRef
go back to reference Mion F, Pellissier S, Garros A, Damon H, Roman S & Bonaz B (2020) Transcutaneous auricular vagus nerve stimulation for the treatment of irritable bowel syndrome: a pilot, open-label study. Bioelectronics in Medicine 3 (1). Mion F, Pellissier S, Garros A, Damon H, Roman S & Bonaz B (2020) Transcutaneous auricular vagus nerve stimulation for the treatment of irritable bowel syndrome: a pilot, open-label study. Bioelectronics in Medicine 3 (1).
go back to reference Pellissier S, Bonaz B (2017) The place of stress and emotions in the irritable bowel syndrome. Vitam Horm 103:327–354PubMedCrossRef Pellissier S, Bonaz B (2017) The place of stress and emotions in the irritable bowel syndrome. Vitam Horm 103:327–354PubMedCrossRef
go back to reference Peters SL, Muir JG, Gibson PR (2015) Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther 41(11):1104–1115PubMedCrossRef Peters SL, Muir JG, Gibson PR (2015) Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther 41(11):1104–1115PubMedCrossRef
go back to reference Rangan V, Ballou S, Shin A, Camilleri M; Beth Israel Deaconess Medical Center GI Motility Working Group; Lembo A (2020) Use of treatments for irritable bowel syndrome and patient satisfaction based on the IBS in america survey. Gastroenterology 158(3):786-788.e1CrossRef Rangan V, Ballou S, Shin A, Camilleri M; Beth Israel Deaconess Medical Center GI Motility Working Group; Lembo A (2020) Use of treatments for irritable bowel syndrome and patient satisfaction based on the IBS in america survey. Gastroenterology 158(3):786-788.e1CrossRef
go back to reference Redgrave J, Day D, Leung H, Laud PJ, Ali A, Lindert R, Majid A (2018) Safety and tolerability of transcutaneous vagus nerve stimulation in humans; a systematic review. Brain Stimul 11(6):1225–1238PubMedCrossRef Redgrave J, Day D, Leung H, Laud PJ, Ali A, Lindert R, Majid A (2018) Safety and tolerability of transcutaneous vagus nerve stimulation in humans; a systematic review. Brain Stimul 11(6):1225–1238PubMedCrossRef
go back to reference Sahn B, Pascuma K, Kohn N, Tracey KJ, Markowitz JF (2023) Transcutaneous auricular vagus nerve stimulation attenuates inflammatory bowel disease in children: a proof-of-concept clinical trial. Bioelectronic Medicine 9(1):23PubMedPubMedCentralCrossRef Sahn B, Pascuma K, Kohn N, Tracey KJ, Markowitz JF (2023) Transcutaneous auricular vagus nerve stimulation attenuates inflammatory bowel disease in children: a proof-of-concept clinical trial. Bioelectronic Medicine 9(1):23PubMedPubMedCentralCrossRef
go back to reference Selye H (1936) A syndrome produced by diverse nocuous agents. Nature 138:132CrossRef Selye H (1936) A syndrome produced by diverse nocuous agents. Nature 138:132CrossRef
go back to reference Shi X, Hu Y, Zhang B, Li W, Chen JD, Liu F (2021) Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation. JCI Insight 6(14):e150052PubMedPubMedCentralCrossRef Shi X, Hu Y, Zhang B, Li W, Chen JD, Liu F (2021) Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation. JCI Insight 6(14):e150052PubMedPubMedCentralCrossRef
go back to reference Sinniger V, Pellissier S, Fauvelle F, Trocmé C, Hoffmann D, Vercueil L, Cracowski JL, David O, Bonaz B (2020) A 12-month pilot study outcomes of vagus nerve stimulation in Crohn’s disease. Neurogastroenterol Motil 32(10):e13911PubMedCrossRef Sinniger V, Pellissier S, Fauvelle F, Trocmé C, Hoffmann D, Vercueil L, Cracowski JL, David O, Bonaz B (2020) A 12-month pilot study outcomes of vagus nerve stimulation in Crohn’s disease. Neurogastroenterol Motil 32(10):e13911PubMedCrossRef
go back to reference Smith GD (2006) Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome. J Clin Nurs 15(6):678–684PubMedCrossRef Smith GD (2006) Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome. J Clin Nurs 15(6):678–684PubMedCrossRef
go back to reference Stanculete MF, Dumitrascu DL, Drossman D (2021) Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome J Gastrointestin Liver Dis 30(4), 517–525. Taché Y, Bonaz B (2007) Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 117(1):33–40CrossRef Stanculete MF, Dumitrascu DL, Drossman D (2021) Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome J Gastrointestin Liver Dis 30(4), 517–525. Taché Y, Bonaz B (2007) Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 117(1):33–40CrossRef
go back to reference Targownik LE, Benchimol EI, Witt J, Bernstein CN, Singh H, Lix L, Tennakoon A, Zubieta AA, Coward S, Jones J, Kuenzig E, Murthy SK, Nguyen GC, Peña-Sánchez JN, Kaplan G (2019) The effect of initiation of anti-TNF therapy on the subsequent direct health care costs of inflammatory Bowel disease. Inflamm Bowel Dis 25(10):1718–1728PubMedCrossRef Targownik LE, Benchimol EI, Witt J, Bernstein CN, Singh H, Lix L, Tennakoon A, Zubieta AA, Coward S, Jones J, Kuenzig E, Murthy SK, Nguyen GC, Peña-Sánchez JN, Kaplan G (2019) The effect of initiation of anti-TNF therapy on the subsequent direct health care costs of inflammatory Bowel disease. Inflamm Bowel Dis 25(10):1718–1728PubMedCrossRef
go back to reference Teicher MH, Samson JA, Anderson CM, Ohashi K (2016) The effects of childhood maltreatment on brain structure, function and connectivity. Nat Rev Neurosci 17(10):652–666PubMedCrossRef Teicher MH, Samson JA, Anderson CM, Ohashi K (2016) The effects of childhood maltreatment on brain structure, function and connectivity. Nat Rev Neurosci 17(10):652–666PubMedCrossRef
go back to reference Torres J, Ellul P, Langhorst J, Mikocka-Walus A, Barreiro-de Acosta M, Basnayake C, Ding NJS, Gilardi D, Katsanos K, Moser G, Opheim R, Palmela C, Pellino G, Van der Marel S, Vavricka SR (2019) European Crohn’s and colitis organisation topical review on complementary medicine and psychotherapy in inflammatory Bowel disease. J Crohns Colitis 13(6):673–685ePubMedCrossRef Torres J, Ellul P, Langhorst J, Mikocka-Walus A, Barreiro-de Acosta M, Basnayake C, Ding NJS, Gilardi D, Katsanos K, Moser G, Opheim R, Palmela C, Pellino G, Van der Marel S, Vavricka SR (2019) European Crohn’s and colitis organisation topical review on complementary medicine and psychotherapy in inflammatory Bowel disease. J Crohns Colitis 13(6):673–685ePubMedCrossRef
go back to reference Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A; International Organization for the Study of IBD (2021) STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160(5):1570–1583CrossRef Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A; International Organization for the Study of IBD (2021) STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160(5):1570–1583CrossRef
go back to reference Wetwittayakhlang P, Bessissow T, Lakatos PL (2024) Novel and emerging drugs for the treatment of Crohn’s disease: a review of phase II and III trials. Expert Opin Emerg Drugs 9:1–16 Wetwittayakhlang P, Bessissow T, Lakatos PL (2024) Novel and emerging drugs for the treatment of Crohn’s disease: a review of phase II and III trials. Expert Opin Emerg Drugs 9:1–16
go back to reference Whorwell PJ, Prior A, Faragher EB (1984) Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 2(8414):1232–1234PubMedCrossRef Whorwell PJ, Prior A, Faragher EB (1984) Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 2(8414):1232–1234PubMedCrossRef
go back to reference Wienke C, Grueschow M, Haghikia A, Zaehle T (2023) Phasic, event-related transcutaneous auricular vagus nerve stimulation modifies behavioral, pupillary, and low-frequency oscillatory power responses. J Neurosci 43(36):6306–6319PubMedPubMedCentralCrossRef Wienke C, Grueschow M, Haghikia A, Zaehle T (2023) Phasic, event-related transcutaneous auricular vagus nerve stimulation modifies behavioral, pupillary, and low-frequency oscillatory power responses. J Neurosci 43(36):6306–6319PubMedPubMedCentralCrossRef
go back to reference Zhao M, Gönczi L, Lakatos PL, Burisch J (2021) The Burden of inflammatory bowel disease in Europe in 2020. J Crohns Colitis 15(9):1573–1587PubMedCrossRef Zhao M, Gönczi L, Lakatos PL, Burisch J (2021) The Burden of inflammatory bowel disease in Europe in 2020. J Crohns Colitis 15(9):1573–1587PubMedCrossRef
Metadata
Title
Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis
Author
Bruno Bonaz
Publication date
21-03-2024
Publisher
Springer International Publishing
Published in
Inflammopharmacology / Issue 2/2024
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-024-01446-7

Other articles of this Issue 2/2024

Inflammopharmacology 2/2024 Go to the issue